Brooks Laboratories Q2 Results FY27: PAT Jumps 747.24% to Rs 67.61 Cr, Revenue Rs 19.25 Cr

Brooks Laboratories Ltd (BROOKS) Q2 Results FY27 announced on 7 November 2026, covering the company's financial performance for the July to September quarter. In Brooks Laboratories Q2 Results FY27, revenue came in at Rs 19.25 Cr and PAT at Rs 67.61 Cr. The results date of 7 November 2026 applies to these consolidated results, which compare the quarter with the same period of last year.

This Brooks Laboratories Q2 Results coverage works through the numbers in a fixed order. The results analysis moves from financial highlights to business drivers, then to outlook and risks, and the reader can follow each figure back to the table below.

Click Here – Get Free Investment Predictions

Brooks Laboratories Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 19.25 Cr	Rs 23.45 Cr	-17.91% YoY
Operating Profit	Rs 0.32 Cr	Rs 2.52 Cr	-87.3% YoY
Net Profit (PAT)	Rs 67.61 Cr	Rs 7.98 Cr	+747.24% YoY

Source: company filing for Brooks Laboratories Q2 Results FY27, 7 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Brooks Laboratories Q2 Results: What Stands Out

• Revenue fell 17.91% YoY to Rs 19.25 Cr from Rs 23.45 Cr, which is the softer reading among the three headline lines.
• Net profit rose 747.24% YoY to Rs 67.61 Cr from Rs 7.98 Cr, the largest YoY growth figure in Brooks Laboratories Q2 Results FY27.
• Operating Profit fell 87.3% YoY to Rs 0.32 Cr from Rs 2.52 Cr, moving in the opposite direction to net profit.
• Net profit margin was 351.2% against 34.0% in the comparison quarter, since net profit was larger than revenue this time.
• Revenue slipped 16.2% QoQ from Rs 22.96 Cr, and the performance analysis below places these moves side by side.

Brooks Laboratories Q2 Results FY27: Performance Analysis

Brooks Laboratories reported consolidated revenue of Rs 19.25 Cr for July to September 2026, down 17.91% YoY, while net profit reached Rs 67.61 Cr, up 747.24% YoY. Operating Profit of Rs 0.32 Cr was 87.3% lower than the Rs 2.52 Cr recorded a year earlier.

Revenue and profit pulled in different directions in Brooks Laboratories Q2 Results FY27. Sales eased from Rs 23.45 Cr to Rs 19.25 Cr over the year, and the sequential figure was also lower, at 16.2% below the Rs 22.96 Cr of the previous quarter. Net profit, by contrast, climbed from Rs 7.98 Cr.

In this results analysis, Brooks Laboratories Q2 Results show a net profit margin of 351.2% against 34.0% a year earlier, a ratio that simply reflects net profit exceeding revenue. The supplied figures confirm these quarterly results but do not establish the specific cause of the gap, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Net Profit Growth – The results analysis points first to net profit, which rose 747.2% year on year to Rs 67.61 Cr. That increase sits against a revenue decline of 17.91%, so the profit line, rather than the sales line, carries the headline numbers in Brooks Laboratories Q2 Results FY27.

Net Profit Margin – Net profit margin improved to 351.2% from 34.0% in the comparison quarter. The ratio is measured on consolidated revenue of Rs 19.25 Cr, which means it exceeds 100% only because net profit of Rs 67.61 Cr is larger than revenue.

Return Ratios – Return on equity was 22.27% in FY26 and return on capital employed was 21.72% in FY26. These annual ratios give the quarterly results a reference point for returns earned on shareholder capital and employed capital in the last full fiscal year.

FY27 Outlook After Brooks Laboratories Q2 Results

The full-year picture for FY27 will depend on the quarters still to be reported and on the conditions disclosed later. This results analysis therefore treats Rs 19.25 Cr of revenue and Rs 67.61 Cr of net profit as the second-quarter reading, not as a full-year marker.

Investors tracking Brooks Laboratories Q2 Results FY27 can compare the next consolidated filing with this one, looking at whether revenue moves back toward the Rs 22.96 Cr of the previous quarter and how net profit compares with the Rs 67.61 Cr now reported. Those comparisons lead naturally to the risks.

Key Risks to Watch After Brooks Laboratories Q2 Results FY27

Revenue Decline

Revenue declined 17.9% year on year to Rs 19.25 Cr in the latest quarter. A lower top line against the Rs 23.45 Cr of a year earlier is the first item to monitor in later filings.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs -1.79 Cr to Rs 67.61 Cr over the last 5 quarters. After Brooks Laboratories Q2 Results FY27, that range shows how far the profit line has moved between reports.

Sequential Revenue Drop

Revenue was down 16.2% quarter on quarter from Rs 22.96 Cr. Combined with the YoY growth figure of minus 17.91%, the decline has now appeared on both comparison bases.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Brooks Laboratories Q2 Results FY27 present a consolidated quarter in which revenue of Rs 19.25 Cr fell while net profit of Rs 67.61 Cr rose sharply. Read alongside the Financial Highlights table, Brooks Laboratories Q2 Results are best judged on the next set of quarterly results. Use the Univest app to follow later filings, and consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Brooks Laboratories Q2 Results FY27

What are Brooks Laboratories Q2 Results FY27?

Ans. Brooks Laboratories Q2 Results FY27 are the consolidated quarterly results of Brooks Laboratories for July to September 2026, declared on 7 November 2026, so the key headline figures sit in the Financial Highlights table.

What is the results date for Brooks Laboratories Q2 Results FY27?

Ans. The results date for Brooks Laboratories in Brooks Laboratories Q2 Results FY27 is 7 November 2026, which means the figures cover the July to September quarter, as set out in the opening section.

What revenue was reported in Brooks Laboratories Q2 Results FY27?

Ans. Brooks Laboratories reported revenue of Rs 19.25 Cr in Brooks Laboratories Q2 Results FY27, compared with Rs 23.45 Cr a year earlier, as the Financial Highlights table and the performance analysis show.

What net profit was reported in Brooks Laboratories Q2 Results FY27?

Ans. Net profit in Brooks Laboratories Q2 Results FY27 was Rs 67.61 Cr against Rs 7.98 Cr in the comparison quarter, which is why the Key Takeaways section calls it the largest YoY move.

How much YoY growth did revenue show in Brooks Laboratories Q2 Results FY27?

Ans. Revenue showed YoY growth of minus 17.91% in Brooks Laboratories Q2 Results FY27, a decline from Rs 23.45 Cr to Rs 19.25 Cr, and the performance analysis explains how this compares with profit.

Did net profit rise or fall in Brooks Laboratories Q2 Results?

Ans. Net profit rose 747.24% YoY in Brooks Laboratories Q2 Results, from Rs 7.98 Cr to Rs 67.61 Cr, while revenue moved the other way, as the performance analysis section notes.

What was the Operating Profit in Brooks Laboratories Q2 Results FY27?

Ans. Operating Profit in Brooks Laboratories Q2 Results FY27 was Rs 0.32 Cr, down 87.3% from Rs 2.52 Cr a year earlier, which means it moved against net profit, as the takeaways section shows.

Are Brooks Laboratories Q2 Results consolidated results or standalone results?

Ans. Brooks Laboratories Q2 Results are consolidated results, so the Rs 19.25 Cr revenue and Rs 67.61 Cr net profit reflect the combined position, as stated in the Quick Answer.

What business factors shaped Brooks Laboratories Q2 Results FY27?

Ans. The disclosed factors in Brooks Laboratories Q2 Results FY27 are the 747.2% rise in net profit, the 351.2% net profit margin and FY26 return ratios of 22.27% and 21.72%, covered in the business factors section.

What are the key risks after Brooks Laboratories Q2 Results FY27?

Ans. Key risks after Brooks Laboratories Q2 Results FY27 are the 17.9% YoY revenue decline, volatile quarterly net profit and a 16.2% QoQ revenue drop, all of which are described in the risks section.

What is the outlook after Brooks Laboratories Q2 Results?

Ans. The outlook after Brooks Laboratories Q2 Results rests on the remaining FY27 quarters, so full-year results will depend on later filings, which the outlook section ties back to the revenue and net profit now reported.

Where can I find the complete Brooks Laboratories Q2 Results FY27 data?

Ans. The complete Brooks Laboratories Q2 Results FY27 data is in the Financial Highlights table above, and the Univest Screener lets readers follow the same consolidated figures, as mentioned in the conclusion.